| 26/05/2022 |
11:20 to 13:30 |
Acute leukemias |
12:40 to 13:00 |
What is the precise time to indicate CAR-T in
refractory ALL? The golden window that cannot be missed |
Speaker |
| 26/05/2022 |
11:20 to 13:30 |
Acute leukemias |
13:00 to 13:30 |
Q&A |
Discussant |
| 27/05/2022 |
16:00 to 19:10 |
Multiple Myeloma |
18:00 to 18:20 |
When
is the precise moment to indicate CAR-T in the refractory multiple myeloma?
Past the timing, opportunity lost |
Speaker |
| 27/05/2022 |
16:00 to 19:10 |
Multiple Myeloma |
18:20 to 18:40 |
Will
sequencing be important with newer therapies? Could you burn bridges? |
Speaker |
| 27/05/2022 |
16:00 to 19:10 |
Multiple Myeloma |
18:40 to 19:10 |
Q&A |
Discussant |
| 28/05/2022 |
12:40 to 15:30 |
Aggressive Lymphomas |
13:40 to 14:00 |
First relapse in DLBCL: induction chemo and auto
transplant. Wait, not so fast… |
Speaker |
| 28/05/2022 |
12:40 to 15:30 |
Aggressive Lymphomas |
14:40 to 15:00 |
Who is a candidate for CAR-T in Diffuse Large
B-cell lymphoma? The window of opportunity that cannot be missed and
opportunities for the future |
Speaker |
| 28/05/2022 |
12:40 to 15:30 |
Aggressive Lymphomas |
15:00 to 15:30 |
Q&A |
Discussant |
